Precigen (PGEN) Net Margin (2012 - 2026)

Precigen (PGEN) reported Net Margin of 34.1% for Q1 2026, up 400415.0% year-over-year from N/an in Q1 2025, and up 93.38% quarter-over-quarter from 514.85% in Q4 2025.

Precigen (PGEN) Net Margin (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 14 years of Net Margin data on file, last reported at 34.1% in Q1 2026.

  • Net Margin for Q1 2026 came in at 34.1%, up 400415.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1376.68% (up 222696.0% YoY), and the FY2025 annual result was 4436.62%, down 122044.0% from the prior year.
  • Net Margin climbed to 34.1% in Q1 2026 per PGEN's latest filing, from 514.85% in the prior quarter.
  • Over five years, Net Margin peaked at 5429.89% in Q3 2022 and troughed at 78358.82% in Q2 2025.
  • A 4-year average of 9740.85% and a median of 1363.3% in 2024 frame the typical range for Net Margin.
  • On a YoY basis, Net Margin climbed as much as 1316319 bps in 2025 and fell as far as 6962301 bps in 2025.
  • A 4-year view of Net Margin shows it stood at 5429.89% in 2022, then tumbled by 125 bps to 1363.3% in 2024, then soared by 62 bps to 514.85% in 2025, then surged by 93 bps to 34.1% in 2026.
  • Business Quant data shows PGEN's Net Margin at 34.1% in Q1 2026, 514.85% in Q4 2025, and 78358.82% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.82%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 34.53%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Precigen 1.27 Bn 1.27 Bn 20.69 Mn -34.10%

Historic Data

Download Data
DateValue
Mar 31, 2026 -34.10%
Dec 31, 2025 -514.85%
Jun 30, 2025 -78,358.82%
Mar 31, 2025 -4,038.26%
Dec 31, 2024 -1,363.30%
Sep 30, 2024 -2,706.32%
Jun 30, 2024 -8,735.81%
Mar 31, 2024 -17,201.45%
Sep 30, 2022 5,429.89%
Jun 30, 2022 289.39%
Mar 31, 2022 84.29%
Dec 31, 2021 -16.31%
Sep 30, 2021 -103.36%
Jun 30, 2021 285.43%
Mar 31, 2021 18.47%
Dec 31, 2020 -6.78%
Sep 30, 2020 -8.36%
Jun 30, 2020 -90.87%
Mar 31, 2020 -117.81%
Dec 31, 2019 -783.08%